Page last updated: 2024-10-29

ioversol and Heart Disease, Ischemic

ioversol has been researched along with Heart Disease, Ischemic in 2 studies

Research Excerpts

ExcerptRelevanceReference
"In patients with ischemic heart disease, the administration of contrast agents iodixanol, ioversol and gadobutrol improves (due to the effect of dilution) the aggregation of erythrocytes in vivo, but does not change their deformation ability and the percentage of different morphological forms of erythrocytes (discocytes and ehinocytes) in the blood."1.36[Aggregation, deformation and morphology of erythrocytes in patients with ischemic heart disease after injection of ioversol, iodixanol and gadobutrol]. ( Firsov, NN; Kiseleva, OA; ShimanovskiÄ­, NL; Usenko, AN, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nagao, M1
Matsuoka, H1
Kawakami, H1
Higashino, H1
Mochizuki, T1
Murase, K1
Uemura, M1
Kiseleva, OA1
Usenko, AN1
ShimanovskiÄ­, NL1
Firsov, NN1

Trials

1 trial available for ioversol and Heart Disease, Ischemic

ArticleYear
Quantification of myocardial perfusion by contrast-enhanced 64-MDCT: characterization of ischemic myocardium.
    AJR. American journal of roentgenology, 2008, Volume: 191, Issue:1

    Topics: Adult; Aged; Contrast Media; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Fe

2008

Other Studies

1 other study available for ioversol and Heart Disease, Ischemic

ArticleYear
[Aggregation, deformation and morphology of erythrocytes in patients with ischemic heart disease after injection of ioversol, iodixanol and gadobutrol].
    Eksperimental'naia i klinicheskaia farmakologiia, 2010, Volume: 73, Issue:12

    Topics: Aged; Contrast Media; Erythrocyte Aggregation; Erythrocyte Deformability; Erythrocytes; Female; Huma

2010